Iteris (ITI) Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Iteris in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ITI shares.
View ITI analyst ratings or view top-rated stocks.

2 analysts have issued 1 year price targets for Iteris' stock. Their ITI share price forecasts range from $4.50 to $7.00. On average, they predict the company's stock price to reach $5.83 in the next twelve months. This suggests a possible upside of 32.9% from the stock's current price.
View analysts price targets for ITI or view top-rated stocks among Wall Street analysts.

Iteris' stock was trading at $3.11 at the beginning of 2023. Since then, ITI stock has increased by 41.2% and is now trading at $4.39.
View the best growth stocks for 2023 here.

Iteris saw a decline in short interest in May. As of May 15th, there was short interest totaling 85,600 shares, a decline of 5.7% from the April 30th total of 90,800 shares. Based on an average daily trading volume, of 89,700 shares, the short-interest ratio is currently 1.0 days.
View Iteris' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 13th 2023.
View our ITI earnings forecast.

Iteris, Inc. (NASDAQ:ITI) posted its quarterly earnings data on Wednesday, November, 3rd. The technology company reported ($0.05) EPS for the quarter, missing the consensus estimate of $0.01 by $0.06. The technology company earned $33.25 million during the quarter, compared to analysts' expectations of $33.80 million. Iteris had a negative net margin of 11.79% and a negative trailing twelve-month return on equity of 24.92%. During the same quarter last year, the firm earned $0.02 earnings per share.

9 employees have rated Iteris Chief Executive Officer Joe Bergera on Glassdoor.com. Joe Bergera has an approval rating of 100% among the company's employees. This puts Joe Bergera in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Iteris investors own include Energy Transfer (ET), Ford Motor (F), Advanced Micro Devices (AMD), Inseego (INSG), Nokia Oyj (NOK), Novavax (NVAX), OPKO Health (OPK), Strongbridge Biopharma (SBBP), CBL & Associates Properties (CBL) and Enphase Energy (ENPH).

Iteris trades on the NASDAQ under the ticker symbol "ITI."

Iteris' stock is owned by a number of institutional and retail investors. Top institutional investors include Cowen Prime Advisors LLC (7.94%), Private Management Group Inc. (4.20%), Dimensional Fund Advisors LP (2.52%), Royce & Associates LP (1.88%), Royce & Associates LP (1.88%) and BlackRock Inc. (1.77%). Insiders that own company stock include Douglas L Groves, Gerard Mooney, J Joseph Bergera, Ramin M Massoumi, Santiago Subotovsky, Todd Kreter and Tom Thomas.
View institutional ownership trends.

Shares of ITI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ITI stock can currently be purchased for approximately $4.39.

Iteris (NASDAQ:ITI) has a market capitalization of $187.78 million and generates $147.85 million in revenue each year. The technology company earns $-7,080,000.00 in net income (profit) each year or ($0.40) on an earnings per share basis.

The company employs 415 workers across the globe.

Iteris' mailing address is 1700 CARNEGIE AVENUE, SANTA ANA CA, 92705. The official website for the company is www.iteris.com. The technology company can be reached via phone at (512) 716-0808, via email at iti@mkr-group.com, or via fax at 949-270-9401.